A surprising new study suggests that eating a very healthy diet—packed with fruits, vegetables, and whole grains—might be linked to a higher risk of lung cancer in younger non-smokers. Researchers ...

That approval was based on a phase 3 study that demonstrated a 46% reduction in the risk of disease progression or death, and a 27% reduction in the risk of death compared with Tecentriq alone. In ...

Following another phase 3 failure for Gilead Sciences’ Trodelvy, the race to bring a TROP2 antibody-drug conjugate (ADC) to patients with first-line non-small cell lung cancer (NSCLC) has narrowed.

Medical artificial intelligence (AI) faces a fundamental challenge: uncertainty quantification. Artificial neural networks are largely unaware of the limits of their training data and can become ...

CHICAGO—At the world’s largest oncology conference, Ozempic, a diabetes drug, found its way to the center of the conversation. As thousands of attendees bounced between presentations at the American ...

Although cancer treatments are improving fast, prevention has so far been mostly about promoting a healthy lifestyle. But efforts to find preventive drugs and vaccines are starting to bear fruit. New ...

U.K. pharmaceutical group GSK has entered an agreement to acquire U.S.-based specialist oncology biotech Nuvalent for $10.6 billion. The acquisition could help GSK offset a drop in revenue expected ...

The Pentagon on Monday updated its religious affiliation codes after members of the Church of Jesus Christ of Latter-day Saints criticized the list because it did not describe LDS as a "Christian" ...

Researchers around the world are grappling with a vexing problem: why are so many young people developing cancers once considered the purview of old age? This question was prominent at two of the ...

July 3, 2026: We just added around five new Anime Squadron codes to help you get ahead in UPD 0.75. If you can put down the game for one minute to redeem Anime Squadron codes, you might find it worth ...

A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer. Researchers say the ...

Thanks to new treatments, some patients with the disease are living longer — leaving them in limbo for years. Thanks to new treatments, some patients with the disease are living longer — leaving them ...